Grifols, S.A. (GRF.MC) stock analysis

In our weekly check, Grifols, S.A. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 6, red flags: 2.

About Grifols, S.A.

Grifols, S.A. is a Healthcare company (Drug Manufacturers - General) based in Spain, listed on BME as GRF.MC.

What our checks show for GRF.MC

Red flags

• Net debt is 4.6x a year of EBITDA (debt/equity 1.54). That limits room in a downturn and raises refinancing risk.
• The stock has fallen as much as 80% from a peak. Would you have held through that?

Warning signs

• Operating profit covers interest only 2.3 times: a weak year could make the payments hard.
• The gross margin fell by 2.6 points, to 37.2%: costs are rising faster than prices.
• The net margin is only 6.1%: little room if costs rise.
• The stock is still below its previous peak.
• Beta 1.2: the stock usually moves more than the market, both up and down.
• Return on capital (ROCE) is only 6.9%.

Strengths

• The net margin rose by 0.7 points over 5 years, to 6.1%.
• Operating cash flow is 2.42x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 34.3% a year over the next years.
• Analysts expect the net margin to improve by 4.4 points from today's 6.1%.
• Earnings per share grew 29.3% a year over the last 3 years.
• Net profit grew 29.5% a year over the last 3 years.

Next earnings report: 2026-11-02

Similar companies

OGN · ORNBV.HE · BIIB · BAYN.DE

Questions

What grade does Grifols, S.A. (GRF.MC) have?

In our weekly check, Grifols, S.A. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 6, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of GRF.MC stock?

This week's biggest flags for Grifols, S.A.: High debt, Deep past fall, Weak interest cover. In total 8 of 25 checks show a warning or a red flag.

What does Grifols, S.A. do?

Grifols, S.A. is a Healthcare company (Drug Manufacturers - General) based in Spain, listed on BME as GRF.MC.

When does Grifols, S.A. report earnings next?

The next earnings report is expected on 2026-11-02. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis